Christopher Robinson: Early Pregnancy Oxylipins May Signal Risk of Fetal Growth Restriction
Christopher Robinson, Physician, Partner at Charleston Maternal Fetal Medicin, shared a post on LinkedIn about a recent article by Kelly Ferguson et al, published in American Journal of Obstetrics Gynecology, adding:
“Early pregnancy oxylipin markers of inflammation and oxidative stress are associated with small-for-gestational-age birth and specific phenotypes of fetal growth restriction – Pathways of oxylipin production and obstetric relevance.”
Title: Early pregnancy oxylipin markers of inflammation and oxidative stress are associated with small-for-gestational-age birth and specific phenotypes of fetal growth restriction
Authors: Kelly K. Ferguson, Barrett M. Welch, Danielle R. Stevens, Paige A. Bommarito, Ginger L. Milne, John D. Meeker, Matthew L. Edin, Darryl C. Zeldin, David E. Cantonwine, Thomas F. McElrath
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 13, 2026, 04:22Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
-
Sep 13, 2026, 03:40Mizinga Moonze: When Blood Speaks – The Missing Link in Healthcare Sustainability
-
Sep 12, 2026, 17:55Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
-
Sep 12, 2026, 17:49Kalyan Roy: TRAGS – An Emerging Transfusion Safety Concern
-
Sep 12, 2026, 17:48Jason Fung: What Happened to “Statins Save Lives”?
-
Sep 12, 2026, 17:47Eric Topol: Most Supplements and Vitamins Offer Little Proven Benefit